BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22505565)

  • 21. Response: importance of screening for macroprolactin in hyperprolactinaemic sera.
    Jamaluddin FA
    Malays J Pathol; 2013 Dec; 35(2):190. PubMed ID: 24362487
    [No Abstract]   [Full Text] [Related]  

  • 22. Macroenzyme detection by polyethylene glycol precipitation.
    Davidson DF; Watson DJ
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):514-20. PubMed ID: 14503988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin.
    Fahie-Wilson MN
    Clin Chem; 2000 Dec; 46(12):2022-3. PubMed ID: 11106347
    [No Abstract]   [Full Text] [Related]  

  • 24. Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay.
    Whitehead SJ; Cornes MP; Ford C; Gama R
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):61-6. PubMed ID: 25074991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reporting of post-polyethylene glycol prolactin: precipitation by polyethylene glycol 6000 or polyethylene glycol 8000 will change reference intervals for monomeric prolactin.
    Veljkovic K; Servedio D; Don-Wauchope AC
    Ann Clin Biochem; 2012 Jul; 49(Pt 4):402-4. PubMed ID: 22619354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macroprolactinaemia: a biological diagnostic strategy from the study of 222 patients.
    Parlant-Pinet L; Harthé C; Roucher F; Morel Y; Borson-Chazot F; Raverot G; Raverot V
    Eur J Endocrinol; 2015 Jun; 172(6):687-95. PubMed ID: 25755230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperprolactinemia: new assay more specific for the monomeric form does not eliminate screening for macroprolactin with polyethylene glycol precipitation.
    Vieira JG; Tachibana TT; Ferrer CM; Sá Jd; Biscolla RP; Hoff AO; Kanashiro I
    Arq Bras Endocrinol Metabol; 2010 Dec; 54(9):856-7. PubMed ID: 21340180
    [No Abstract]   [Full Text] [Related]  

  • 29. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins.
    Ram S; Harris B; Fernando JJ; Gama R; Fahie-Wilson M
    Ann Clin Biochem; 2008 May; 45(Pt 3):256-9. PubMed ID: 18482912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
    Hattori N
    J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin results for samples containing macroprolactin are method and sample dependent.
    Gilson G; Schmit P; Thix J; Hoffman JP; Humbel RL
    Clin Chem; 2001 Feb; 47(2):331-3. PubMed ID: 11159783
    [No Abstract]   [Full Text] [Related]  

  • 32. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.
    Fahie-Wilson M; Bieglmayer C; Kratzsch J; Nusbaumer C; Roth HJ; Zaninotto M; Plebani M; Hubbuch A; Schneider E
    Clin Lab; 2007; 53(5-6):301-7. PubMed ID: 17605405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of molecular variants of prolactin in human serum, evaluation of a method based on ultrafiltration.
    Landberg E; Wahlberg J; Rydén I; Arvidsson BM; Ekman B
    Clin Chim Acta; 2007 Feb; 376(1-2):220-5. PubMed ID: 17027953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reference intervals for six enzymes after polyethylene glycol precipitation and ultrafiltration.
    Wyness SP; Hunsaker JJ; La'ulu SL; Roberts WL
    Clin Chim Acta; 2011 May; 412(11-12):1161-2. PubMed ID: 21062625
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
    Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
    J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperprolactinaemia caused by antipsychotic drugs: a new application for prolactin assays.
    Ellis A; Fahie-Wilson M
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):287-9. PubMed ID: 20592330
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-prolactin autoantibodies and hyperprolactinaemia.
    Olukoga AO; Kane J
    Eur J Endocrinol; 1995 Oct; 133(4):463-4. PubMed ID: 7581971
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of prolactin: the macroprolactin problem.
    Fahie-Wilson M; Smith TP
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macroprolactin, big-prolactin and potential effects on the misdiagnosis of hyperprolactinemia using the Beckman Coulter Access Prolactin assay.
    Ellis MJ; Livesey JH; Soule SG
    Clin Biochem; 2006 Oct; 39(10):1028-34. PubMed ID: 16919253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyethylene glycol interference in the Immulite prolactin assay: treatment of the calibrators with polyethylene glycol does not improve diagnostic accuracy.
    Rivero A
    Clin Chem Lab Med; 2008; 46(2):296-7. PubMed ID: 18076362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.